Corporate Viewpoint:Effects of support for balancing work and treatment in small and medium-sized companies

Corporate Viewpoint:Effects of support for balancing work and treatment in small and medium-sized companies

Annals of Oncology 30 (Supplement 6): vi54, 2019 doi:10.1093/annonc/mdz380 WORKSHOP 2 : SUPPORT FOR WORKING CANCER SURVIVORS : HEALTHCARE PROVIDERS’ ...

82KB Sizes 0 Downloads 39 Views

Annals of Oncology 30 (Supplement 6): vi54, 2019 doi:10.1093/annonc/mdz380

WORKSHOP 2 : SUPPORT FOR WORKING CANCER SURVIVORS : HEALTHCARE PROVIDERS’ ROLE IN HOSPITAL SETTINGS 1

Support for working cancer survivors: toward collaboration among stakeholders in hospitals, workplaces, and communities

Miyako Takahashi Center for Cancer Control and Information Services, National Cancer Center Owing to improvements in treatments and supportive care, more cancer survivors return to work during and after treatment. Work outcomes are influenced by multiple conditions such as patients’ individual characteristics, health conditions, and work environments. Outcomes are also influenced by the broader conditions of policies and community resources. Although healthcare providers cannot act as ’specialists’ of work-related issues, hospital visits can be considered as precious opportunities for patients, where multi-disciplinary healthcare providers can screen patients in need and provide them with basic work-related support. Healthcare providers will also be able to refer such patients to appropriate specialists both within and outside of the hospital. This presentation gives an outline of current "cancer and work" policies in Japan, and discusses how healthcare providers can effectively collaborate with various stakeholders that interact with working patients.

WS2

3

Support for both medical treatment and workPerspective of an occupational health physician 

Hideki Morimoto Morimoto Occupational Health Physician office There are approximately 100 thousand registered occupational health physicians certified by the Japanese Medical Association, and 31% of physicians have an occupational health qualification. Moreover, among the physicians registered, about 60% are practicing occupational medicine, and 55% of physicians who work in occupational health spend under 10% of their working hours practicing it. Furthermore, there are only 1,128 physicians whose primary work is in occupational health. In order to provide sufficient support to patients for both medical treatment and work, the number of people working in occupational health must increase, and not only some doctors, but all physician and part-time occupational health physicians have to focus on support for it. Medicine and nursing are not the only elements that need to be in place to provide support for both medical treatment and work; knowledge about psychological assessment, labor and career management, and the social security system is also invaluable. In other words, there is also a need for participation from and cooperation between people from a variety of fields in addition to medicine, such as welfare, labor and social security attorneys, as well as the government. While cancer patients are receiving treatment, they also need to solve problems related to work and finances. Patients are likely to be experiencing many things for the first time, including taking time off from work. Having to visit many different offices while

they are unwell is a major burden. Hence, it is important to divide things up so that consultation offices such as cancer consultation and support centers can synthesize content for consultation from the outset and address issues. The role of these centers will become even more important moving forward. We would like to cover the above information along with actual examples and discuss expectations from relevant personnel and departments from the perspective of occupational health physicians.

WS2

4

Corporate Viewpoint:Effects of support for balancing work and treatment in small and medium-sized companies

Tomoko Saito MATSUSHITA INDUSTRY Co.,Ltd. Human Resource Center I. Objectives: Continuous development of corporate business requires pleasant working conditions, assured challenges,and maintaining the physical and mental health of employees.Resignation of employees with cancer could reduce technical capabilities and shake the business foundation.We often hear that many corporate managers of SMEs prioritize sales and profits and are unwilling to spend energy and cost on support for work and treatment balance. We will share the case of our company concerning the method and effects of work-life balance support of SMEs. II. Method: Human Resource Center (HRC),established in 2013,is an independent organization providing one-stop support according to the life stages of employees,from joining the company to retiring. Consultation on cancer treatment,etc.,is resolved working with contract industrial physicians and industrial health nurses. III. Results: HRC’s efforts to support work and treatment balance (examples) 1. Support at each stage: 1.Prevention (cancer screening,site inspection by industrial physician) 2.Treatment period (publication of cancer fight diary in company newsletter, participation of industrial physician in meeting with primary physician) 3. After return to work (work-at-home system),etc. 2. Maturation of the sense of security: Group long-term disablity income indemnity insurance, defined contribution pension,etc. IV. Summary: In SMEs, the priority will be establishing a system to balance cancer treatment and work and enhance the sense of security to increase employee retention, rather than complaining of labor shortages. In the case of internal resource shortages, knowledge of external experts needs to be borrowed to compensate for correct information and knowhow. With one consultation window, data and knowhow will be centralized, further enhancing the quality and response capacity of work-treatment balance support. Establishing a work-treatment balance system will enhance corporate values inexpressible in figures.

C The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. V

All rights reserved. For permissions, please email: [email protected].

Downloaded from https://academic.oup.com/annonc/article-abstract/30/Supplement_6/mdz380.002/5583178 by Goteborgs Universitet user on 05 November 2019

WS2